NCT03460977 2026-04-16A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaPfizerPhase 1 Recruiting453 enrolled
NCT05150691 2026-01-28A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting796 enrolled
NCT02675452 2025-07-09AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid LeukemiaAmgenPhase 1 Terminated141 enrolled 46 charts